javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Speciality Medicines Ltd.
BSE Code 544738
ISIN Demat INE0R0M01014
Book Value 81.03
NSE Code NA
Dividend Yield % 0.00
Market Cap 1651.73
P/E 12.67
EPS 14.83
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
04-Jun-2026 Speciality Medicines NIRAJ RAJNIKANT SHAHSELL 5000021010500000188
04-Jun-2026 Speciality Medicines PARADISE MOON INVESTMENT FUND-ISELL 6000021112660000188
29-May-2026 Speciality Medicines AINUL ANWAR SHAIKHSELL 102000207.8521200700188
29-May-2026 Speciality Medicines ANWAR MOHAMMED SHAIKHSELL 112000207.923284800188
29-May-2026 Speciality Medicines BHAVNA HITESH PATELBUY 69000208.4214380980188
29-May-2026 Speciality Medicines BHAVNA HITESH PATELSELL 5000225.521127600188
29-May-2026 Speciality Medicines FEROZA ANWAR SHAIKHSELL 100000207.8520785000188
29-May-2026 Speciality Medicines NIRAJ RAJNIKANT SHAHBUY 50000207.8510392500188
29-May-2026 Speciality Medicines YASH HITESH PATELBUY 200000207.8541570000188
22-May-2026 Speciality Medicines BHAVNA HITESH PATELBUY 69000208.9514417550188
22-May-2026 Speciality Medicines NEO APEX SHARE BROKING SERVICES LLPSELL 61000208.9512745950188
21-May-2026 Speciality Medicines NEO APEX SHARE BROKING SERVICES LLPBUY 61000219.913413900188
22-Apr-2026 Speciality Medicines YASHVI HITESH PATELBUY 59000278.5716435630188
20-Apr-2026 Speciality Medicines YASHVI HITESH PATELBUY 57000264.9115099870188
17-Apr-2026 Speciality Medicines BHAVNA HITESH PATELBUY 45000246.4511090250188
17-Apr-2026 Speciality Medicines YASH HITESH PATELBUY 50000238.4911924500188
17-Apr-2026 Speciality Medicines YASHVI HITESH PATELBUY 45000215.969718200188
07-Apr-2026 Speciality Medicines AIKYAM CAPITAL PRIVATE LIMITEDSELL 150000134.4320164500188
07-Apr-2026 Speciality Medicines NIRAJ RAJNIKANT SHAHBUY 101000134.4513579450188
07-Apr-2026 Speciality Medicines YASH HITESH PATELBUY 45000133.996029550188
Page 1 of 3
Prev || Next
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.